Development of Vitamin D as a Therapy for Breast Cancer - Phase 2
Trial ID or NCT#
NCT00656019
Status
NOT RECRUITING
Purpose
This study will assess whether levels of vitamin D impact the characteristics of a woman's breast cancer at diagnosis, and whether a short course of vitamin D in women with low levels of vitamin D changes the gene expression of their breast cancers.
Official Title
Development of Vitamin D as a Therapy for Breast Cancer - Phase 2
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: No
Investigator(s)
Kristin Jensen
David Feldman
Contact us to find out if this trial is right for you.
Contact
Charlene Kranz
6504987977
View on ClinicalTrials.gov
